Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at JMP Securities from $24.00 to $7.00. They now have a "market outperform" rating on the stock.
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at Royal Bank of Canada from $50.00 to $48.00. They now have an "outperform" rating on the stock.
HOOKIPA Pharma GAAP EPS of -$1.10, revenue of $4.7M [Seeking Alpha]
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates [Yahoo! Finance]
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates